Piramal Pharma Limited has scheduled its 6th Annual General Meeting (AGM) for July 30, 2026, at 3:00 p.m. IST through Video Conferencing and Other Audio Visual Means. The meeting will be conducted pursuant to the Ministry of Corporate Affairs General Circular No. 03/2025 dated September 22, 2025, and applicable SEBI regulations, permitting virtual meetings without physical presence.

The company informed the stock exchanges regarding the publication of newspaper advertisements to notify equity shareholders about the AGM. The intimation was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The advertisements were published in Business Standard (English) and Mumbai Lakshadweep (Marathi).

The Notice of the AGM along with the weblink for the Annual Report for FY 2025-26 will be sent electronically to members whose email addresses are registered with the company or depositories. Additionally, a letter containing the weblink and QR Code of the AGM notice will be sent to members who have not registered their email addresses, in compliance with Regulation 36(1)(b) of the SEBI Listing Regulations.

Attendance of members attending the AGM through VC/OAVM shall be counted for the purpose of reckoning quorum under Section 103 of the Companies Act, 2013. Members who have not registered their email addresses are encouraged to do so to receive the Notice and Annual Report. As per SEBI regulations, dividends can only be paid through electronic mode, and members must ensure their KYC and bank details are updated.

Members whose shares are lying in the Piramal Pharma Limited Escrow Account must claim their shares by submitting requisite documents to transfer them to their demat account before claiming unclaimed dividends. The filing was signed by Maneesh Sharma, Company Secretary & Compliance Officer of Piramal Pharma Limited.

piramal pharma witnessed a notable block trade on the National Stock Exchange (NSE), with approximately 3,515,258 shares changing hands in a single transaction. The deal was executed at a price of ₹168.22 per share, aggregating to a total transaction value of ₹59.13 crores.

Block Trade Details

The following table summarises the key parameters of the block trade recorded on the NSE:

Block trades of this scale are typically executed by large institutional investors or significant stakeholders and are carried out outside the regular order book to minimise market impact. The transaction in Piramal Pharma reflects notable activity in the stock on the NSE.